Conservative vs Interventional Management of Postsurgical CSF Pseudomeningocele
PSEUDO
Conservative Versus Interventional Management of Postsurgical CSF Pseudomeningocele: A Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
Dear Sir or Madam, You have been invited to participate in a clinical study whose aim is to compare the effectiveness of two different approaches to the treatment of cerebrospinal fluid (CSF) pseudomeningocele - conservative management and interventional treatment (surgical or drainage procedures). CSF pseudomeningocele is a complication that may occur after brain surgery and is characterized by an accumulation of cerebrospinal fluid beneath the skin. At present, there is no clear consensus regarding the optimal treatment approach. How the study will be conducted After enrollment in the study, you will be randomly assigned (by chance) to one of two groups: Conservative management: no surgical intervention, regular follow-up, and wound care. Interventional treatment: simple aspiration/puncture, insertion of a lumbar drain, or reoperation. During the study, you will be followed for a period of 1 year. Follow-up examinations will include clinical assessment and brain imaging (CT or MRI) at 4 months and 12 months after enrollment. Risks associated with the interventional group Simple cyst aspiration/puncture: infection, bleeding into the pseudomeningocele. Lumbar drainage: infection, meningitis, bleeding at the insertion site, cerebrospinal fluid leakage, nerve root irritation, headaches. Reoperation: bleeding, infection, complications related to general anesthesia. Expected duration of participation in the study 12 months Expected total number of participants enrolled in the study 20 participants Benefit of the study The aim of the study is to compare the effect of surgical intervention with conservative management. Compensation for participation Participation in this study is not associated with any financial compensation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 15, 2026
CompletedFirst Posted
Study publicly available on registry
May 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2030
May 29, 2026
May 1, 2026
4 years
May 15, 2026
May 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CSF Leakage or Tension pseudomeningocoele
New-onset wound CSF leakage requiring revision surgery, or pseudomeningocele associated with severe headaches not responsive to analgesics.
12 months
Secondary Outcomes (4)
Infection
12 months
Glasgow Outcome Scale Extended (GOSE)
12 months
Absorption of the Pseudomeningocoele
12 months
Pain
12 months
Study Arms (2)
Conservative
NO INTERVENTIONPatients managed without surgical procedures, except for skin sutures.
Interventional
EXPERIMENTALPatients undergoing local treatment - lumbar drainage insertion, simple wound puncture, fibrin glue or any combination.
Interventions
after aspiration of the CSF a fibrin glue is injected into the pseudomeningocele
Revision surgery in order to prevent future pseudomeninogocele formation
Eligibility Criteria
You may qualify if:
- Pseudomeningocele after elective intracranial surgery
- Willing and able to give informed consent
- No prior cranial or spinal surgical intervention
- Pseudomeningocele Palpation Scale (PPS) II-IV, no severe pain of the PMC (VAS 7-10) - Tension MK
You may not qualify if:
- PMC following emergency or trauma surgery
- Known or suspected infection at the PMC site at recruitment
- Severe comorbidities preventing participation (e.g. terminal illness, organ failure)
- Conditions requiring urgent unrelated surgical intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Military University Hospital Prague
Prague, Prague, 16000, Czechia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Neurosurgeon, Consultant, Head of Department of Cranial Surgery.
Study Record Dates
First Submitted
May 15, 2026
First Posted
May 29, 2026
Study Start
November 1, 2025
Primary Completion (Estimated)
November 1, 2029
Study Completion (Estimated)
November 1, 2030
Last Updated
May 29, 2026
Record last verified: 2026-05